TALi Digital Limited operates as a medical technology company in Australia.
TALi Digital Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.028|
|52 Week High||AU$0.026|
|52 Week Low||AU$0.061|
|1 Month Change||-9.68%|
|3 Month Change||-24.32%|
|1 Year Change||-3.45%|
|3 Year Change||-9.68%|
|5 Year Change||-3.45%|
|Change since IPO||-99.48%|
Recent News & Updates
Here's Why We're Watching TALi Digital's (ASX:TD1) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
What Can We Make Of TALi Digital's (ASX:TD1) CEO Compensation?
Glenn Smith became the CEO of TALi Digital Limited ( ASX:TD1 ) in 2017, and we think it's a good time to look at the...
|TD1||AU Healthcare Services||AU Market|
Return vs Industry: TD1 underperformed the Australian Healthcare Services industry which returned 41.1% over the past year.
Return vs Market: TD1 underperformed the Australian Market which returned 21.4% over the past year.
Stable Share Price: TD1 is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: TD1's weekly volatility (9%) has been stable over the past year.
About the Company
TALi Digital Limited operates as a medical technology company in Australia. It provides diagnostic and therapeutic solutions for cognitive function and behavior. The company also offers TALi TRAIN, a game-based training program for young children to enhance the underlying attentional processes; TALi Portal, which allows healthcare professionals, educators, and parents to assess a child’s daily performance and identify strengths and weaknesses to tailor the program to child’s needs; and TALi Detect that consists of seven tests to profile cognitive attention capabilities of a child.
TALi Digital Fundamentals Summary
|TD1 fundamental statistics|
Is TD1 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|TD1 income statement (TTM)|
|Cost of Revenue||AU$2.62m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.0052|
|Net Profit Margin||-885.08%|
How did TD1 perform over the long term?See historical performance and comparison
Is TALi Digital undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate TD1's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate TD1's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: TD1 is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.
PE vs Market: TD1 is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TD1's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TD1 is good value based on its PB Ratio (3.6x) compared to the AU Healthcare Services industry average (4.1x).
How is TALi Digital forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as TALi Digital has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has TALi Digital performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TD1 is currently unprofitable.
Growing Profit Margin: TD1 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: TD1 is unprofitable, and losses have increased over the past 5 years at a rate of 6.7% per year.
Accelerating Growth: Unable to compare TD1's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TD1 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (39.5%).
Return on Equity
High ROE: TD1 has a negative Return on Equity (-66.95%), as it is currently unprofitable.
How is TALi Digital's financial position?
Financial Position Analysis
Short Term Liabilities: TD1's short term assets (A$5.6M) exceed its short term liabilities (A$611.1K).
Long Term Liabilities: TD1's short term assets (A$5.6M) exceed its long term liabilities (A$2.0M).
Debt to Equity History and Analysis
Debt Level: TD1 is debt free.
Reducing Debt: TD1 had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TD1 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TD1 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23.3% each year
What is TALi Digital current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate TD1's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TD1's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TD1's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TD1's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TD1's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Glenn Smith, BA Econ, MBA, has been Managing Director of TALI Digital Limited (formerly known as Novita Healthcare Ltd) since May 10, 2018 and served as its Chief Operating Officer until March 2020. Mr...
CEO Compensation Analysis
Compensation vs Market: Glenn's total compensation ($USD328.02K) is about average for companies of similar size in the Australian market ($USD303.33K).
Compensation vs Earnings: Glenn's compensation has increased whilst the company is unprofitable.
Experienced Management: TD1's management team is considered experienced (2.7 years average tenure).
Experienced Board: TD1's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: TD1 insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.4%.
TALi Digital Limited's employee growth, exchange listings and data sources
- Name: TALi Digital Limited
- Ticker: TD1
- Exchange: ASX
- Founded: 2004
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: AU$26.093m
- Shares outstanding: 931.91m
- Website: https://talidigital.com
Number of Employees
- TALi Digital Limited
- 19 William Street
- Level 5
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/22 15:39|
|End of Day Share Price||2021/10/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.